Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07455058 · ClinicalTrials.gov registry record
Water Vapor Ablation for Prostate Cancer: Long-Term Registry
A clinical trial, sponsored by Francis Medical.
- Recruiting
- Registry status
- 2,500
- Enrollment target
NCT07455058 is a clinical trial that is actively recruiting participants, run by Francis Medical. The registered enrollment target is 2,500 participants.
The verdict
NCT07455058 is actively recruiting participants, sponsored by Francis Medical.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsored Vanquish therapy study (as applicable).
Interventions
- DEVICE Vanquish Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2026-06-05 |
| Est. Completion | 2041-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07455058
The ClinicalTrials.gov registry entry for NCT07455058 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Francis Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vanquish Therapy is the first listed.
NCT07455058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07455058 about?
NCT07455058 is a clinical study titled "Water Vapor Ablation for Prostate Cancer: Long-Term Registry". The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or m...
What is the current status of trial NCT07455058?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2026-06-05. Estimated completion is 2041-07-31.
What interventions are being tested in trial NCT07455058?
The interventions under investigation include: Vanquish Therapy (DEVICE).
Who is sponsoring clinical trial NCT07455058?
This trial is sponsored by Francis Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.